Obesity Clinical Trial
Official title:
A Study of the Function of Hormones Present In Taste Buds
The purpose of this study is to find out whether the hormones in the taste buds are affected by tasting and eating food, and also whether these hormone levels are affected by an increase in body weight or type 2 diabetes.
Cephalic phase of insulin secretion is regulated by autonomic and endocrine responses to
food-related sensory stimulation such as sight, smell, and taste. Human taste perception
comprises of at least five distinct qualities: bitterness, saltiness, sourness, sweetness,
and umami, the sensation elicited by glutamate, commonly found in protein (meat, fish, and
legumes) and flavor enhancer such as monosodium glutamate (MSG).
Both the sweet and umami taste stimuli had been shown to illicit cephalic-phase insulin
release in rats. Oral sensory stimulation in human with modified sham feeding (MSF where food
is smelled, chewed, but not swallowed) had been shown to enhance insulin release during the
cephalic phase, lower postprandial glucose level, and improve glucose tolerance in healthy
subjects. The loss of pre-absorptive insulin response has been shown to impair glucose
tolerance. Furthermore, patients with type 2 diabetes and their first degree relatives had
been shown to have impairment of sweet taste.
Recently, glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) have been found in the taste
cells located in the taste buds of mice (unpublished data). These new findings raise several
interesting questions of whether strict tasting of food without ingestion may stimulate
secretion of GLP-1 and PYY from the taste cells, whether their secretion is involved in the
afferent input of the cranial nerves, and whether this secretion is impaired in obesity and
in patients with pre-diabetes or type 2 diabetes. We also want to investigate whether
different tastants, such as sweet versus umami, and different food contents such as percent
fat versus carbohydrate compositions, would elicit different hormonal responses.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |